Understanding Familial Avascular Necrosis of the Femoral Head
At a Glance
Familial avascular necrosis of the femoral head (FANFH) is an inherited condition that causes bone death in the hip joint, usually affecting adults in their 20s or 30s. Early diagnosis allows for joint-preserving treatments, while advanced cases are effectively treated with hip replacement.
Receiving a diagnosis of Familial Avascular Necrosis of the Femoral Head (FANFH) can feel overwhelming, especially when it affects multiple members of a family. Unlike standard hip arthritis that typically appears in older age, FANFH often impacts people in their teens, 20s, or 30s [1][2]. While the news is difficult, understanding the biological cause and the clear treatment pathways available can provide a sense of control and a roadmap for the future.
Understanding the Condition
To understand FANFH, it is helpful to define two key terms:
- Osteonecrosis (also called Avascular Necrosis): This occurs when the blood supply to a section of bone is interrupted. Without blood, the bone tissue dies (necrosis), loses its structural integrity, and can eventually collapse [3].
- Femoral Head: This is the “ball” at the top of your thigh bone (femur) that fits into the hip socket.
In the familial version of this disease, the bone death isn’t caused by an injury or lifestyle factors, but by a genetic blueprint that makes the hip joint more vulnerable.
The Genetic Connection: COL2A1
Recent medical research has identified that many cases of FANFH are caused by mutations in the COL2A1 gene [4]. This gene provides instructions for making type II collagen, a protein that is essential for the strength and structure of cartilage and bone [4][5].
When this gene has a mutation, the collagen it produces may be unstable or “misfolded.” This weakens the bone structure in the hip, making it more likely that the microcirculation (tiny blood vessels) within the femoral head will be compromised [4][6]. Because this is an autosomal dominant condition, it can be passed from one parent to their children, which is why multiple generations of a family may experience hip issues early in life [4].
Why Age Matters
One of the most striking aspects of FANFH is the age of onset. While standard osteoarthritis (wear-and-tear of the joint) usually appears in patients over 60, FANFH is a leading cause of hip pain and disability in younger adults [1][2]. Because it hits during the prime of life, early diagnosis is vital to explore all available options before the joint surface collapses [7][8].
Stabilizing Facts and Treatment Paths
While the diagnosis is serious, there are well-established medical pathways designed to manage the condition and restore function.
- High Bilateral Risk: Because FANFH is genetic, it has a high rate of affecting both hips (bilateral presentation) [9]. Even if you only have pain in one hip, doctors will proactively monitor the other to catch any issues early.
- Joint-Preserving Surgery: If the disease is caught in the early stages (before the “ball” of the hip has collapsed), doctors may use techniques like core decompression. This involves drilling a small hole into the dead bone to relieve pressure and encourage new blood vessels to grow [1][10]. This can often reduce pain and delay the need for a full replacement for years [11][12].
- Total Hip Arthroplasty (THA): If the bone has already collapsed or the pain is severe, a hip replacement is the gold standard. Modern hip replacements using ceramic or advanced polyethylene materials are highly successful in young, active patients [13][14].
- High Quality of Life: Research shows that young patients who undergo hip replacement for avascular necrosis achieve significant symptomatic and functional improvement, often returning to high levels of activity with reduced pain [15][16].
Screening for the Family
Because FANFH is genetic, a diagnosis for one person often serves as a “warning light” for the rest of the family. Doctors may recommend:
- Genetic Counseling: To understand the risks for children or siblings [17].
- Early Screening: Using MRI (the most accurate tool for early detection) to check asymptomatic family members for the earliest signs of the disease [18][19]. Catching the condition before symptoms start provides the best chance for joint-preserving treatments [7].
Common questions in this guide
What causes familial avascular necrosis of the femoral head?
At what age does familial avascular necrosis usually start?
What treatments are available before a hip replacement is needed?
Should my family members be tested for FANFH?
Will I eventually need a hip replacement?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my family history, should I (and my relatives) be tested for the COL2A1 gene mutation?
- 2.What stage is my hip disease currently in, and has the femoral head begun to collapse?
- 3.Am I a candidate for joint-preserving surgery, such as core decompression, to delay the need for a hip replacement?
- 4.Given my age, how many years can I expect a total hip replacement to last before needing a revision?
- 5.Are there other joints or systems (like my vision or hearing) that we should monitor due to the COL2A1 association?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (19)
- 1
[Total hip replacement in avascular femoral head necrosis].
Betsch M, Tingart M, Driessen A, et al.
Der Orthopade 2018; (47(9)):751-756 doi:10.1007/s00132-018-3617-5.
PMID: 30094647 - 2
Increasing trend toward joint-preserving procedures for hip osteonecrosis in the United States from 2010 to 2019.
Ng MK, Kobryn A, Golub IJ, et al.
Arthroplasty (London, England) 2023; (5(1)):23 doi:10.1186/s42836-023-00176-5.
PMID: 37122010 - 3
Avascular necrosis of the hip.
Lamb JN, Holton C, O'Connor P, Giannoudis PV
BMJ (Clinical research ed.) 2019; (365()):l2178 doi:10.1136/bmj.l2178.
PMID: 31147356 - 4
COL2A1 mutation (c.3508G>A) leads to avascular necrosis of the femoral head in a Chinese family: A case report.
Liu F, Xiong Z, Liu Q, et al.
Molecular medicine reports 2018; (18(1)):254-260 doi:10.3892/mmr.2018.8984.
PMID: 29750297 - 5
COL2A1 Mutation (c.611G>C) Leads to Early-Onset Osteoarthritis in a Chinese Family.
Li P, Wang A, Li J, et al.
International journal of general medicine 2021; (14()):2569-2574 doi:10.2147/IJGM.S310050.
PMID: 34168485 - 6
Pathogenicity effects of a COL2A1 missense mutation (c.1594G>C) in cartilage development.
Zhou J, Yuan T
Translational pediatrics 2025; (14(7)):1511-1519 doi:10.21037/tp-2025-79.
PMID: 40800180 - 7
Corticosteroids induced avascular necrosis of hip, a "long COVID-19" complication: Case report.
Annam P, Manda A, Myneni UK, et al.
Annals of medicine and surgery (2012) 2022; (82()):104753 doi:10.1016/j.amsu.2022.104753.
PMID: 36168319 - 8
Current concepts on osteonecrosis of the femoral head.
Moya-Angeler J, Gianakos AL, Villa JC, et al.
World journal of orthopedics 2015; (6(8)):590-601 doi:10.5312/wjo.v6.i8.590.
PMID: 26396935 - 9
IGF-1 polymorphisms modulate the susceptibility to osteonecrosis of the femoral head among Chinese Han population.
Wang J, Liu H, Zhang Q
Medicine 2019; (98(23)):e15921 doi:10.1097/MD.0000000000015921.
PMID: 31169709 - 10
Core Decompression for Osteonecrosis of the Femoral Head.
Vega JF, Cervantes JE, Yee BF, Nho SJ
Video journal of sports medicine 2026; (6(1)):26350254251368924 doi:10.1177/26350254251368924.
PMID: 41674793 - 11
Efficacy of autologous stem cell therapy in femoral head avascular necrosis: a comparative study.
Ulusoy İ, Yılmaz M, Kıvrak A
Journal of orthopaedic surgery and research 2023; (18(1)):799 doi:10.1186/s13018-023-04297-0.
PMID: 37875891 - 12
Hip Preservation With Autologous Osteoblast Cell-Based Treatment in Osteonecrosis of the Femoral Head.
Palekar G
Orthopedics 2021; (44(2)):e183-e189 doi:10.3928/01477447-20201210-02.
PMID: 33316818 - 13
Mid-term survivorship and clinical results of cementless total hip arthroplasty for steroid-induced avascular necrosis.
Karatas ME, Kemah B, Soylemez MS, Saglam N
Northern clinics of Istanbul 2024; (11(3)):219-224 doi:10.14744/nci.2023.38107.
PMID: 39005747 - 14
Outcomes of total hip arthroplasty in patients with osteonecrosis of the femoral head-a current review.
Pierce TP, Elmallah RK, Jauregui JJ, et al.
Current reviews in musculoskeletal medicine 2015; (8(3)):246-51 doi:10.1007/s12178-015-9283-x.
PMID: 26045086 - 15
Functional Outcomes of Cementless Total Hip Arthroplasty in Avascular Necrosis of the Hip: A Prospective Study.
Karimi S, Kumar S, Ahmed F, et al.
Cureus 2020; (12(8)):e10136 doi:10.7759/cureus.10136.
PMID: 33005548 - 16
Long-term outcomes of total hip arthroplasty in patients younger than 55 years: a systematic review of the contemporary literature
Mei XY, Gong YJ, Safir O, et al.
Canadian journal of surgery. Journal canadien de chirurgie 2019; (62(4)):249-258 doi:10.1503/cjs.013118.
PMID: 31348632 - 17
Identification of an IGF1 mutation (c.15+3G>A) in familial osteonecrosis of the femoral head: A case report.
Xu Q, Song D, Wu Z, et al.
Medicine 2021; (100(1)):e23705 doi:10.1097/MD.0000000000023705.
PMID: 33429739 - 18
Accuracy of MRI diagnosis of early osteonecrosis of the femoral head: a meta-analysis and systematic review.
Zhang YZ, Cao XY, Li XC, et al.
Journal of orthopaedic surgery and research 2018; (13(1)):167 doi:10.1186/s13018-018-0836-8.
PMID: 29973239 - 19
[MRI relevance in femoral head osteonecrosis: 3 case studies].
Traore O, Moussali N, Wakrim S, et al.
Le Mali medical 2016; (31(1)):25-33.
PMID: 30079661
This page provides educational information about familial avascular necrosis of the femoral head (FANFH). It is not a substitute for professional medical advice, diagnosis, or treatment from your orthopedic surgeon or genetic counselor.
Get notified when new evidence is published on Familial avascular necrosis of femoral head.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.